Composition for the prevention and/or treatment of the cytotoxic effects inducedby the use of immunosuppressive agents

Details for Australian Patent Application No. 2001241031 (hide)

Owner Sigma-Tau Healthscience S.P.A.

Inventors Cavazza, Claudio

Agent Davies Collison Cave

Pub. Number AU-B-2001241031

PCT Pub. Number WO01/64204

Priority RM200A000107 02.03.00 IT

Filing date 20 February 2001

Wipo publication date 12 September 2001

Acceptance publication date 27 October 2005

International Classifications

A61K 031/00

Event Publications

27 October 2005 Application Accepted

  Published as AU-B-2001241031

1 December 2005 Corrigenda

  Applications Accepted - Name Index Under the name Sigma-Tau Healthscience S.P.A., Application No. 2001241031, under INID (31) correct the number to read RM2000A000107, under INID (54) correct the title to read Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents.

23 February 2006 Standard Patent Sealed

5 March 2009 Assignment Registered

  Sigma-Tau Healthscience S.P.A. The patent has been assigned to Sigma Tau - Industrie Farmaceutiche Riunite S.p.A

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001241032-MACHINE FOR STACKING AND BONDING SUB-BOARDS OF A MULTILAYER BOARD FOR A PRINTED CIRCUIT AND METHOD OF FABRICATION OF A MULTILAYER BOARD

2001241030-Composition for the prevention and/or treatment of vascular diseases, comprising propionyl L-carnitine and coenzyme Q10